- Home
- GSK
as 06-28-2024 4:00pm EST
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
| Founded: | 1715 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 84.7B | IPO Year: | N/A |
| Target Price: | $46.33 | AVG Volume (30 days): | 4.5M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | 3.91% | Dividend Payout Frequency: | Quarterly |
| EPS: | 2.76 | EPS Growth: | -69.52 |
| 52 Week Low/High: | $33.67 - $45.93 | Next Earning Date: | 07-31-2024 |
| Revenue: | $39,410,256,410 | Revenue Growth: | 5.69% |
| Revenue Growth (this year): | 7.74% | Revenue Growth (next year): | 6.34% |
Latest GSK plc (Each representing two) News
GSK Breaking Stock News: Dive into GSK Ticker-Specific Updates for Smart Investing
Insider Monkey
3 days ago
GSK plc (GSK): Did This Healthcare Stock Show a Strong Performance in Q1?
Morningstar Research
3 days ago
Analyst Report: GSK plc
Yahoo Finance Video
3 days ago
GSK stock falls as CDC shifts RSV vaccine recommendation
The Wall Street Journal
3 days ago
GSK Shares Slump After CDC Narrows Age Recommendation for RSV Shots
Benzinga
3 days ago
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
Investing.com
3 days ago
Micron, Levi Strauss, Walgreens and International Paper fall premarket
Benzinga
4 days ago
Why Is Moderna Stock Trading Lower On Wednesday?
Investing.com
4 days ago
Moderna shares decline, RSV vaccine efficacy lags behind competitors
Share on Social Networks:
Disclaimer
The information presented on this page, "GSK GSK plc (Each representing two) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.